Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug

Tamoxifen is a drug that has been in worldwide use for the treatment of estrogen receptor (ER)-positive breast cancer for over 30 years; it has been used in both the metastatic and adjuvant settings. Tamoxifen's approval for breast cancer risk reduction dates back to 1998, after results from th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzeroni, Matteo, Serrano, Davide, Dunn, Barbara K, Heckman-Stoddard, Brandy M, Lee, Oukseub, Khan, Seema, Decensi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053098/
https://www.ncbi.nlm.nih.gov/pubmed/23106852
http://dx.doi.org/10.1186/bcr3233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053098/
https://www.ncbi.nlm.nih.gov/pubmed/23106852
http://dx.doi.org/10.1186/bcr3233

Ejemplares similares